Search

everythinglearnresearchcommunity

for

Search:↓

Scientists created tiny particles loaded with a hair growth drug, minoxidil, that specifically target hair follicles and skin cells to potentially improve hair growth.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Vitamin D boosts a specific gene activity in kidney cells that could improve heart and kidney function.

The L457(3.43)R mutation in the human lutropin receptor causes increased activity and hormone insensitivity, leading to precocious puberty.

Lack of Vitamin D receptor changes skin structure and increases certain immune cells in the skin.

Androgens and SARMs play a role in body mass, frailty, skin health, and hair growth, and are used in treating prostate cancer, acne, and hair loss, with potential for new uses and improved versions in the future.

TLR4 is important in aging-related diseases and could be a new treatment target.

Endothelial TLR2 is crucial for timely wound healing, but HFSC TLR2 is not needed.

As skin cells mature, vitamin D receptor levels decrease while retinoid X receptor α levels increase.

CMG2 and TEM8 receptors have distinct roles in skin and growth disorders, affecting collagen breakdown and growth.

δ-GABAA receptors affect alcohol consumption based on the estrous cycle and influence movement regardless of the cycle.

Progesterone and its byproducts control a specific receptor in the brain independently of progesterone receptors, affecting conditions related to the menstrual cycle.

Mice without active or present vitamin D receptors maintain normal blood sugar control and islet gene expression when calcium levels are normal.

Vitamin D receptor helps control hair growth genes in skin cells.

Vitamin D receptor gene variations are not linked to alopecia areata.

Allopregnanolone is needed for certain brain processing issues caused by D1 dopamine receptor activation.

Activating TRPV3 channels stops hair growth by killing hair follicle cells.

Lack of vitamin D receptor causes hair loss in mice by allowing certain genes to overactivate.

The mineralocorticoid receptor temporarily affects mouse skin development, but the glucocorticoid receptor has a more lasting impact.

A vitamin D receptor mutation causes rickets and affects immune responses.

The Androgen Receptor could be a target for treating diseases like cancer, but more research is needed to confirm the effectiveness of potential treatments.

Pregnancy-related hormone changes affect Y1 receptor gene expression in mice.

Increased Toll-like receptors in blood cells may contribute to alopecia areata and could be a target for new treatments.

The vitamin D receptor can act without its usual activating molecule, affecting hair growth and skin cancer, but its full range of actions is not well understood.

We need better ways to test and understand SARMs to make safer and more effective treatments.

Certain variations in the vitamin D receptor gene are linked to an increased risk of polycystic ovary syndrome.

Vitamin D receptor helps protect skin cells from UV damage and supports their growth.

New mutations in the VDR gene cause vitamin D-resistant rickets without hair loss.

Three new gene mutations cause rickets and hair loss, treatable with high calcium and calcidol, but hair regrowth is rare.

Vitamin D receptor can control the hairless gene linked to hair loss even without vitamin D.